Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-26 @ 12:41 AM
NCT ID:
NCT04460560
Group ID:
EG000
Title:
Open-Label Terlipressin
Description:
All prospective patients receive open-label Terlipressin.
Terlipressin: For the first dose of terlipressin, each vial will be reconstituted with 5 mL of sterile 0.9% sodium chloride solution and administered intravenously as a bolus injection and given over 1 minute at a dose of 0.5 mg.
For continuous infusion, the dose of terlipressin is to be dissolved in 0.9% sodium chloride solution and infused with a pump
Deaths Number Affected:
14
Deaths Number At Risk:
None
Serious Number Affected:
26
Serious Number At Risk:
50
Other Number Affected:
0
Other Number At Risk:
50
Study:
NCT04460560
Results Section:
NCT04460560
Adverse Events Module:
NCT04460560